Biobank: The Belgian Virtual Tumourbank (Belgium)

Primary purpose: To centralize and provide accessibility to residual human tumour samples for researchers, enabling the discovery of diagnostic and prognostic markers and the development of new therapies for the benefit of cancer patients.

Sponsor, manager or home institution: Belgian Cancer Registry (BCR).

Available type of information: Primary Tumour Classification (ICD10 codes); Patients (estimation); Tumour tissue samples (estimation); Conservation mode of the tumour tissue samples (estimation); Additional patient samples (estimation).

Data level: Patient level.

Number of Records: Number of records information [1].

Date Range: Unknown.

Cancer Areas of Interest: Lip (C00); Base of tongue (C01); Tongue (C02); Gum (C03); Floor of mouth (C04); Palate (C05); Mouth, non-otherwise specified (NOS) (C06); Parotid gland (C07); Salivary glands, NOS (C08); Tonsil (C09); Oropharynx (C10); Nasopharynx (C11); Pyriform sinus (C12); Hypopharynx (C13); Lip, oral cavity and pharynx, NOS (C14); Oesophagus (C15); Stomach (C16); Small intestine (C17); Colon (C18); Rectosigmoid junction (C19); Rectum (C20); Anus and anal canal (C21); Liver and intrahepatic bile ducts (C22); Gallbladder (C23); Biliary tract, NOS (C24); Pancreas (C25); Other ill-defined digestive organs (C26); Nasal cavity and middle ear (C30); Accessory sinuses (C31); Larynx (C32); Trachea (C33); Bronchus and lung (C34); Thymus (C37); Heart, mediastinum and pleura (C38); Respiratory system and intrathoracic organs, NOS (C39); Bone and articular cartilage (C40, C41); Malignant melanoma of skin (C43); Malignant neoplasms of skin (C44); Mesothelioma (C45); Kaposi's sarcoma (C46); Soft tissues (C47, C49); Retroperitoneum and peritoneum (C48); Breast (C50); Vulva (C51); Vagina (C52); Cervix uteri (C53); Corpus uteri (C54); Uterus (C55); Ovary (C56); Female genital organs, NOS (C57); Placenta (C58); Penis (C60); Prostate (C61); Testis (C62); Male genital organs, NOS (C63); Kidney (C64); Renal pelvis (C65); Ureter (C66); Bladder (C67); Urinary organs, NOS (C68); Eye and adnexa (C69); Meninges (C70); Brain (C71); Spinal cord, cranial nerves and central nervous system NOS (C72); Thyroid gland (C73); Adrenal gland (C74); Endocrine glands, NOS (C75); Hodgkin's disease (C81); Non-Hodgkin-lymphoma (C82-C86); Malignant immunoproliferative diseases (C88); Multiple myeloma (C90); Lymphoid leukaemia (C91); Myeloid leukaemia (C92); Monocytic leukaemia (C93); Leukaemia other (C94-C95); Lymphoid, haematopoietic and related tissue, NOS (C96); Other and ill-defined sites (C76); Unknown primary site (C80); Myeloproliferative disorders (C94); Myelodysplastic syndromes (C95).

Data access: Not publicly available. Instructions to request data for restricted content [2].

Contact information: Information [3].